Aquapheresis is a medical technology designed to remove excess salt and water from the body safely, predictably, and effectively from patients with a condition called fluid overload. It removes the excess salt and water and helps to restore a patient's proper …

What is Aquapheresis (Ultrafiltration)? Aquapheresis is a treatment done to remove extra water from the body that is causing problems for one or more organs. First, a soft plastic tube, called a catheter, is placed in one of your child’s large veins.

Aquapheresis is a technology that assists in removing excess salt and water from the body. It is commonly used in patients suffering from fluid overload. The aim of the treatment is to remove the excess salt and water in an attempt to maintain a proper euvolemia.

May 8, 2023 · Aquapheresis is a form of slow continuous ultrafiltration where blood is removed by applying negative pressure by the machine, which is then passed through the unique filter across which a set fraction of plasma water is filtered each minute before it …

Today Aquapheresis is an effective and continually growing treatment available for heart failure patients, which provides dramatic results; safely and effectively removing excess salt and water.

The AVOID-HF (Aquapheresis versus Intravenous Diuretics and Hospitalization for Heart Failure) trial tested the hypothesis that patients hospitalized for HF treated with adjustable ultrafiltration (AUF) would have a longer time to first HF event within 90 days after hospital discharge than those receiving adjustable intravenous loop diuretics ...

Aquapheresis therapy, delivered by the Aquadex SmartFlow System, uses a simplified approach to ultrafiltration for the removal of salt and water in patients with Fluid Overload.

Sep 4, 2020 · Background: Aquapheresis (AQ) consists of the extracorporeal extraction of plasma water from the vascular space across a semipermeable membrane in response to a transmembrane pressure gradient. The primary utilization of AQ has been in the management of patients with diuretic resistant heart failure with a treatment goal directed to quickly ...

Jan 28, 2016 · The AVOID-HF (Aquapheresis versus Intravenous Diuretics and Hospitalization for Heart Failure) trial, was designed as a multicenter, 1-to-1 randomized study of 810 hospitalized HF patients. The patients were randomized to ultrafiltration or adjustable intravenous loop …

A recent RCT showed that ultrafiltration (aquapheresis) lead to fewer 90-day heart failure and cardiovascular events compared to adjustable intravenous diuretics, while causing more study product-related serious adverse events.